GSK is forecasting lower 2008 earnings due in part to lower sales of the Avandia drug. Obviously, the Avandia sales figures have decreased dramtically during the last year as studies have indicated that it increases the risk of heart attack and stroke. More ... http://www.thestar.com/Business/article/301369
Posted by Louisville, Kentucky lawyer: Larry Jones 1-888-KYLAW22
